Congenital muscular dystrophies (CMDs), are heterogeneous autosomal recessive disorders. Their severe manifestations consist of early hypotonia and weakness, markedly delayed motor milestones and contractures, often associated with joint deformities1. Histological changes seen in muscle biopsies consist of large variations in muscle fibre size, a few necrotic and regenerating fibres and a marked increase in endomysial collagen tissue. Diagnosis is based on clinical features and on morphological changes. In several CMD cases, we have demonstrated an absence of one of the components of the extracellular matrix around muscle fibres, the merosin M chain2, now referred to as the α2 chain of laminin-2 (ref. 3). We localized this CMD locus to chromosome 6q2 by homozygosity mapping and linkage analysis4. The laminin α2 chain gene (LAMA2) maps to the same region on chromosome 6q22-23 (ref. 5). We therefore investigated LAMA2 for the presence of disease-causing mutations in laminin α2 chain-deficient CMD families and now report splice site and nonsense mutations in two families leading presumably to a truncated laminin α2 protein.
Subscribe to Journal
Get full journal access for 1 year
only $18.75 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Banker, B.Q. in Myology (eds Engel, A.G. & Franzini-Amstrong, C.) 1275–1289 (McGraw-Hill Book Company, New York, 1994).
Tomé, F.M.S. et al. Congenital muscular dystrophy with merosin deficiency. C. R. Acad. Sci. Paris 317, 351–357 (1994).
Burgeson, R.E. et al. A new nomenclature for the laminins. Matrix Biol. 14, 209–211 (1994).
Hillaire, D. et al. Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping. Hum. molec. Genet. 3, 1657–1661 (1994).
Vuolteenaho, R. et al. Human laminin M chain (merosin): complete primary structure, chromosomal assignment, and expression of the M and A chain in human fetal tissues. J. Cell Biol. 124, 381–394 (1994).
Chelly, J., Concordet, J.P., Kaplan, J.C. & Kahn, A. Illegitimate transcription: transcription of any gene in any cell type. Proc. natn. Acad. Sci. U.S.A. 86, 2617–2621 (1989).
Gee, S.H. et al. Laminin-binding protein 120 from brain is closely related to dystrophin-associated glycoprotein, dystroglycan, and binds with high affinity to the major heparin domain of laminin. J. biol. Chem. 268, 14972–14980 (1993).
Sunada, Y., Bernier, S.M., Kosak, C.A., Yamada, Y. & Campbell, K.P. Deficiency of merosin in dystrophic dy mice and genetic linkage of the laminin M chain gene to the dy locus. J. biol. Chem. 269, 13759–13732 (1994).
Ervasti, J.M. & Campbell, K.P. Membrane organization of the dystrophin-glycoprotein complex. Cell 66, 1121–1131 (1991).
Campbell, K.P. Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell 80, 675–679 (1995).
Xu, H., Wu, X-R., Werner, U.M. & Engvall, E. Murine muscular dystrophy caused by a mutation in the laminin α2 (Lama 2) gene. Nature Genet. 8, 297–302 (1995).
Arahata, K. et al. Laminin in animal models for muscular dystrophy. Defect of laminin M in skeletal and cardiac muscles and peripheral nerve of the homozygous dystrophic dy/dy mice. Proc. Japan Acad. 69, 259–264 (1993).
Dubowitz, V. 22nd ENMC sponsored workshop on congenital muscular dystrophy held in Baarn, The Netherlands, 14–16 May 1993. Neuromusc. Disord. 4, 75–81 (1994).
Leivo, I. & Engvall, E. Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast, is expressed late in nerve and muscle development. Proc. natn. Acad. Sci. U.S.A. 85, 1544–1548 (1988).
Engvall, E., Earwicker, D., Haaparanta, T., Ruoslahti, E. & Sanes, J.R. Distribution and isolation of four laminin variants; tissue restricted distribution of heterotrimers assembled from five different subunits. Cell Regul. 1, 731–740 (1990).
Chirgwin, J.M., Przybyla, A.E., MacDonald, R.J. & Rutter, W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294–5299 (1979).
Don, R.H., Cox, P.T., Wainwright, B.J., Baker, K. & Mattick, J.S. “Touchdown” PCR to circumvent spurious priming during gene amplification. Nucl. Acids Res. 19, 4008 (1991).
About this article
Cite this article
Helbling-Leclerc, A., Zhang, X., Topaloglu, H. et al. Mutations in the laminin α2–chain gene (LAMA2) cause merosin–deficient congenital muscular dystrophy. Nat Genet 11, 216–218 (1995) doi:10.1038/ng1095-216
From cytogenetics to cytogenomics: whole-genome sequencing as a first-line test comprehensively captures the diverse spectrum of disease-causing genetic variation underlying intellectual disability
Genome Medicine (2019)
Improvement of motor conduction velocity in hereditary neuropathy of LAMA2-CMD dy/dy mouse model by glatiramer acetate
Clinical Neurophysiology (2019)
Trends in Cell Biology (2019)
Early skeletal muscle pathology and disease progress in the dy3K/dy3K mouse model of congenital muscular dystrophy with laminin α2 chain-deficiency
Scientific Reports (2019)
Trends in Molecular Medicine (2019)